Mepivacaine 是一种叔胺,用作局部麻醉剂。
Mepivacaine hydrochloride binds to specific voltage-gated sodium ion channels in neuronal cell membranes, which inhibits both sodium influx and membrane depolarization. This leads to a blockage of nerve impulse initiation and conduction and results in a reversible loss of sensation. Compared to other local anesthetics, this agent has a more rapid onset and moderate duration of action.
Mepivacaine hydrochloride has a reasonably rapid onset (more rapid than that of procaine) and medium duration of action (shorter than that of procaine).
Mepivacaine hydrochloride displays a preferential use-dependent block of Na(v)1.8, S(-)-bupivacaine displays a preference for TTXs Na(+) channels.
对马的测试表明,与根据以前解剖的,乳胶注射后得到的假定相比,mepivacaine在相邻关节结构间具有更大的扩撒,与关节造影研究形成对比。经历膝关节镜检查患者中,与神经刺激相比较,超声处理使1.5% mepivacaine阻断坐骨神经所需的最低有效麻醉剂体积(MEAV50)减少37%。在犬齿和前臼齿中,lidocaine制剂与肾上腺素相比,3%mepivacaine的使用使麻醉时间间隔更短。
类别
有毒物质
毒性分级
中毒
急性毒性
腹腔-小鼠 LD50: 117 毫克/公斤; 静脉-小鼠 LD50: 35 毫克/公斤
可燃性危险特性
热分解排出有毒氮氧化物烟雾
储运特性
库房低温通风干燥
灭火剂
水, 二氧化碳, 泡沫, 干粉